Prehypertension

Korean Circulation Journal

Volumn 38, Issue 1, 2008, Pages 1-6

  Hong, Kyung Soon ^a  

^a Hallym University   (South Korea)

Author keywords

Blood pressure; Prehypertension; Prevalence

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN HEXETIL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIET THERAPY; DISEASE COURSE; DRUG WITHDRAWAL; HIGH RISK POPULATION; HUMAN; HYPERTENSION; KOREA; LIFESTYLE MODIFICATION; OBESITY; PATIENT COUNSELING; PHYSICAL ACTIVITY; PREHYPERTENSION; PREVALENCE; REVIEW; UNITED STATES; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

EID: 39549090652     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2008.38.1.1     Document Type: Review

References (44)

1. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003;289:2560-72.
2. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevevtion, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
3. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46.
4. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men. JAMA 2002;287:1003-10.
5. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13.
6. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee Guidelines: new challenges of the old problem. Arch Intern Med 2004;164:2126-34.
7. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med 2004;164:2113-8.
8. Qureshi AI, Suri MF, Kirmani JF, Divani AA. Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000. Med Sci Monit 2005;11:CR403-9.
9. Korea Institute for Health and Social Affaires. National health and nutrition examination in Korea, 2005. Ministry of Health and Welfare; 2005.
10. Hong KS, Jeong JY, Jang SN, et al. The prevalence and related risk factors of prehypertension among local residents aged 45 or over in Chuncheon city. Korean Circ J 2006;36:535-42.
11. Chiu YH, Wu SC, Tseng CD, Yen MF, Chen TH. Progression of pre-hypertension, stage 1 and 2 hypertension (JNC 7): a population-based study in Keelung, Taiwan (Keelung Community-based Integrated Screening No. 9). J Hypertens 2006;24:821-8.
12. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001;358:1682-6.
13. Winegarden CR. From "prehypertension" to hypertension?: additional evidence. Ann Epidemiol 2005;15:720-5.
14. Julius S, Nesbitt SD, Egan BM, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006;354:1685-97.
15. Hong KS, Choi MG, Kim DH, et al. Rate and related factors of progression to hypertension among prehypertensive local residents aged 45 or over in Chuncheon city. Korean Circ J 2007;1: in press.
16. Okosun IS, Boltri JM, Anochie LK, Chandra K. Racial/ethnic differences in prehypertension in American adults: population and relative attributable risk of abdominal obesity. J Hum Hypertens 2004;18:849-55.
17. Tsai PS, Ke TL, Huang CJ, et al. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hypertens 2005;23:1355-60.
18. Cordero A, Laclaustra M, Leon M, et al. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. Am J Hypertens 2006;19:189-96.
19. Zhang Y, Lee ET, Devereux RB, et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample. Hypertension 2006;47:410-4.
20. Grotto I, Grossman E, Huerta M, Sharabi Y. Prevalence of pre-hypertension and associated cardiovascular risk profiles among young Israeli adults. Hypertension 2006;48:254-9.
21. Choi KM, Park HS, Han JH, et al. Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001. J Hypertens 2006;24:1515-21.
22. Chrysohoou C, Pitsavos C, Panagiotakos DB, Skoumas J, Stefanadis C. Association between prehypertension status and inflammatory markers related to atherosclerotic disease. Am J Hypertens 2004;17:568-73.
23. King DE, Egan BM, Mainous AG 3rd, Geesey ME. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens 2004;6:562-8.
24. Papadopoulos DP, Makris TK, Krespi PG, et al. Adiponectin and resistin plasma levels in healthy individuals with prehypertension. J Clin Hypertens 2005;7:729-33.
25. Toikka JO, Laine H, Ahotopa M, et al. Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension. Hypertension 2000;36:929-33.
26. Ikram MK, Wittemen JC, Vingerling JR, Breteler MM, Hofman A, de Jong PT. Retinal vessel diameters and risk of hypertension. Hypertension 2006;47:189-94.
27. Lee JE, Kim YG, Choi YH, Huh W, Kim DJ, Oh HY. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension 2006;47:962-7.
28. Liszka HA, Mainous AG 3rd, King DE, Everett CJ, Egan BM. Prehypertension and cardiovascular morbidity. Ann Fam Med 2005;3:294-9.
29. Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med 2006;119:133-41.
30. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345:1291-7.
31. Baidinger B, Schwarz C, Jaggy C. Cardiovascular risk factors, BMI and mortality in a cohort of Swiss males (1976-2001) with high-sum-assured life insurance cover. J Insur Med 2006;38:44-53.
32. Qureshi AI, Suri MF, Kirmani JF, Divani AA, Mohmmad Y. Is prehypertension a risk factor for cardiovascular diseases? Stroke 2005;36:1859-63.
33. Hsia J, Margolis KL, Eaton CB, et al. Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation 2007;115:855-60.
34. Hansen TW, Staessen JA, Zhang H, et al. Cardiovascular outcome in relation to progression to hypertension in the Copenhagen MONICA cohort. Am J Hypertens 2007;20:483-91.
35. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure in overweight people with high normal blood pressure. Arch Intern Med 1997;157:657-67.
36. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-92.
37. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension. Eur Heart J 2007;28:1462-536.
38. Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004;328:634-40.
39. Chockalingam A, Ganesan N, Venkatesan S, et al. Patterns and predictors of prehypertension among "healthy" urban adults in India. Angiology 2005;56:557-63.
40. Ramos E, Barros H. Prevalence of hypertension in 13-year-old adolescents in Porto, Portugal. Rev Port Cardiol 2005;24:1075-87.
41. Seo HJ, Kim SG, Kim CS, Chang YK, Park IG. The incidence and risk factors of hypertension that developed in a male-workers' cohort for 3 years. Korean J Prev Med 2006;39:229-34.
42. Kanauchi M, Kanauchi K, Hashimoto T, Saito Y. Metabolic syndrome and new category 'pre-hypertension' in a Japanese population. Curr Med Res Opin 2004;20:1365-70.
43. Jago R, Harrell JS, McMurray RG, Edelstein S, El Ghormli L, Bassin S. Prevalence of abnormal lipid and blood pressure values among an ethnically diverse population of eighth-grade adolescents and screening implications. Pediatrics 2006;117:2065-73.
44. Whelton PK, Appel LJ, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA 1998;279:839-46.